AGT and endothelial dysfunction: The results reported, in this study, demonstrate that verteporfin inhibits AngII-induced YAP/TAZ activation in vivo and in vitro, reduces vascular inflammation, and improves endothelial dysfunction in AngII hypertensive mice in vivo. Our results suggest that the Hippo/YAP pathway may play a role in AngII-induced vascular injury.